Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anne-Maria Fiorino"'
Autor:
Gloria Solano-Aguilar, Aleksey Molokin, Christine Botelho, Anne-Maria Fiorino, Bryan Vinyard, Robert Li, Celine Chen, Joseph Urban, Harry Dawson, Irina Andreyeva, Miriam Haverkamp, Patricia L Hibberd
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147426 (2016)
We examined gene expression of whole blood cells (WBC) from 11 healthy elderly volunteers participating on a Phase I open label study before and after oral treatment with Lactobacillus rhamnosus GG-ATCC 53103 (LGG)) using RNA-sequencing (RNA-Seq). El
Externí odkaz:
https://doaj.org/article/f0fff06a8b3f48879a18a0d35538f6b3
Autor:
Emiley A. Eloe-Fadrosh, Arthur Brady, Jonathan Crabtree, Elliott F. Drabek, Bing Ma, Anup Mahurkar, Jacques Ravel, Miriam Haverkamp, Anne-Maria Fiorino, Christine Botelho, Irina Andreyeva, Patricia L. Hibberd, Claire M. Fraser
Publikováno v:
mBio, Vol 6, Iss 2 (2015)
ABSTRACT A mechanistic understanding of the purported health benefits conferred by consumption of probiotic bacteria has been limited by our knowledge of the resident gut microbiota and its interaction with the host. Here, we detail the impact of a s
Externí odkaz:
https://doaj.org/article/0b3624cc8ec24f3daa577cd469facad7
Autor:
Patricia L Hibberd, Lauren Kleimola, Anne-Maria Fiorino, Christine Botelho, Miriam Haverkamp, Irina Andreyeva, Debra Poutsiaka, Claire Fraser, Gloria Solano-Aguilar, David R Snydman
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113456 (2014)
BACKGROUND:Although Lactobacillus rhamnosus GG ATCC 53103 (LGG) has been consumed by 2 to 5 million people daily since the mid 1990s, there are few clinical trials describing potential harms of LGG, particularly in the elderly. OBJECTIVES:The primary
Externí odkaz:
https://doaj.org/article/26704da20cad4a91b463a9838ca19013
Autor:
Ashley Y. Shaw, Anne-Maria Fiorino, Michael Hidrue, Natalie Y. Johnson, Joanne Miao, Jennifer Searl Como, Anna Spiro, Elizabeth T. Cafiero Fonseca, Jason H. Wasfy, Alexy Arauz Boudreau
Publikováno v:
Population Health Management. 25:608-615
A tiered pediatric Asthma Population Health Management Program (APHMP), based on evidence-based practices, that differentially targets populations for intervention based on rising risk for high utilization and disease complications was implemented at
Autor:
Sameer Gupta, Elizabeth T. Cafiero-Fonseca, Timothy G. Ferris, Sepideh Ashrafzadeh, Anne-Maria Fiorino, Maryam M. Asgari
Publikováno v:
J Am Acad Dermatol
Publikováno v:
European journal of clinical nutrition
Live-attenuated influenza vaccine (LAIV) protects against influenza by mucosal activation of the immune system. Studies in animals and adults have demonstrated that probiotics improve the immune response to mucosally delivered vaccines. We hypothesiz
Autor:
Bing Ma, Jacques Ravel, Irina Andreyeva, Anne-Maria Fiorino, Patricia L. Hibberd, Arthur Brady, Anup Mahurkar, Emiley A. Eloe-Fadrosh, Miriam Haverkamp, Jonathan Crabtree, Claire M. Fraser, Elliott F. Drabek, Christine Botelho
Publikováno v:
mBio
mBio, Vol 6, Iss 2 (2015)
mBio, Vol 6, Iss 2 (2015)
A mechanistic understanding of the purported health benefits conferred by consumption of probiotic bacteria has been limited by our knowledge of the resident gut microbiota and its interaction with the host. Here, we detail the impact of a single-org
Autor:
Gloria Solano-Aguilar, Aleksey Molokin, Christine Botelho, Bryan T. Vinyard, Miriam Haverkamp, Joseph F. Urban, Anne-Maria Fiorino, Patricia L. Hibberd
Publikováno v:
The FASEB Journal. 29
Annual vaccination against seasonal influenza in the U.S. is recommended for all persons aged 蠅 6 months. A moderate effectiveness for influenza vaccines of approximately 60% has been estimated. Li...
Autor:
Claire M. Fraser, David R. Snydman, Debra D. Poutsiaka, Anne-Maria Fiorino, Irina Andreyeva, Patricia L. Hibberd, Christine Botelho, Gloria Solano-Aguilar, Miriam Haverkamp, Lauren Kleimola
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 12, p e113456 (2014)
PLoS ONE, Vol 9, Iss 12, p e113456 (2014)
Background Although Lactobacillus rhamnosus GG ATCC 53103 (LGG) has been consumed by 2 to 5 million people daily since the mid 1990s, there are few clinical trials describing potential harms of LGG, particularly in the elderly. Objectives The primary
Autor:
Gloria Solano-Aguilar, Celine Chen, Miriam Haverkamp, Christine Botelho, Anne-Maria Fiorino, Patricia L. Hibberd, Linda Wang, Aleksey Molokin, Joseph F. Urban, Harry D. Dawson
Publikováno v:
The FASEB Journal. 27